clinical trial · NCT04985682
A Study of ADVATE in People With Hemophilia A in India
Baxalta now part of Shire·phase4·completed·n = 50
Hemophilia AADVATE
brief summary
The main aim of this study is to learn more about side effects of Advate when given as standard treatment to people with hemophilia A who have already been treated. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study. Participants will need to visit the study doctor 5 times in total during the study. During these visits, study data will be collected by the study doctor.
started
Jan 14, 2022
primary completion
Feb 10, 2023
completion
Feb 10, 2023
last updated
Mar 7, 2024
official title
Phase 4, Multicenter, Prospective, Interventional, Post-Marketing Study in Hemophilia A Patients in India Receiving ADVATE as On-Demand or Prophylaxis Under Standard Clinical Practice
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol